Skye Bioscience Stock (NASDAQ: SKYE) stock price, news, charts, stock research, profile.
Open | $3.16 |
Close | $3.14 |
Volume / Avg. | 5.14M / 243.89K |
Day Range | $2.95 - $3.50 |
52 Wk Range | 1.44 - 19.41 |
Market Cap | $97.39M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 29 |
Short Interest | 5.7% |
Days to Cover | 8.13 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Skye Bioscience (NASDAQ:SKYE) through any online brokerage.
Other companies in Skye Bioscience’s space includes: Molecular Partners (NASDAQ:MOLN), Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT) and Adverum Biotechnologies (NASDAQ:ADVM).
Skye Bioscience has a consensus price target of $18.40.
The stock price for Skye Bioscience (NASDAQ: SKYE) is $3.21 last updated September 20, 2024 at 7:58 PM EDT.
There are no upcoming dividends for Skye Bioscience.
Skye Bioscience’s Q3 earnings are confirmed for Saturday, November 9, 2024.
There is no upcoming split for Skye Bioscience.
Skye Bioscience is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.